Chao Yan

3.2k total citations · 2 hit papers
76 papers, 2.0k citations indexed

About

Chao Yan is a scholar working on Molecular Biology, Biomedical Engineering and Toxicology. According to data from OpenAlex, Chao Yan has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Biomedical Engineering and 10 papers in Toxicology. Recurrent topics in Chao Yan's work include Bioactive Compounds and Antitumor Agents (10 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Nanoplatforms for cancer theranostics (6 papers). Chao Yan is often cited by papers focused on Bioactive Compounds and Antitumor Agents (10 papers), Genomics, phytochemicals, and oxidative stress (6 papers) and Nanoplatforms for cancer theranostics (6 papers). Chao Yan collaborates with scholars based in China, United States and United Kingdom. Chao Yan's co-authors include David Ross, David Siegel, Dan Theodorescu, Ruijuan Qu, Zunyao Wang, Zhang‐Peng Chen, Tengfei Huang, Nannan Wu, Xiangyu Liu and Yumeng Qi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

Chao Yan

71 papers receiving 2.0k citations

Hit Papers

Cannabidiol inhibits human glioma by induction of lethal ... 2021 2026 2022 2024 2021 2023 50 100 150

Peers

Chao Yan
Min Kim South Korea
Bin Sun China
Ying Dong Australia
Chao Yan
Citations per year, relative to Chao Yan Chao Yan (= 1×) peers Yanting Zhang

Countries citing papers authored by Chao Yan

Since Specialization
Citations

This map shows the geographic impact of Chao Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Yan more than expected).

Fields of papers citing papers by Chao Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Yan. The network helps show where Chao Yan may publish in the future.

Co-authorship network of co-authors of Chao Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Yan. A scholar is included among the top collaborators of Chao Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Yan. Chao Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Xinyi, et al.. (2025). Nerve infiltration of bladder cancer predicts response to immunotherapy. Biochemical and Biophysical Research Communications. 761. 151687–151687.
2.
Yan, Chao, Xiang Zhu, Yingying Ren, et al.. (2025). Protein-based nano delivery systems focusing on protein materials, fabrication strategies and applications in ischemic stroke intervention: A review. International Journal of Biological Macromolecules. 311(Pt 1). 143645–143645.
3.
Yao, Yilong, et al.. (2025). WNT5B regulates myogenesis and fiber type conversion by affecting mRNA stability. International Journal of Biological Sciences. 21(9). 3934–3948. 1 indexed citations
4.
Lü, Xinyi, et al.. (2025). Neuro-immune-cancer interactions: Mechanisms and therapeutic implications for tumor modulation. 10. 100119–100119. 1 indexed citations
5.
Zhang, Yifan, Yixuan Zhang, Yudong Qiu, et al.. (2025). CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Cancer Letters. 622. 217713–217713. 1 indexed citations
7.
Fang, Zhengzou, Zhihui Yan, Chao Yan, et al.. (2024). Polydopamine nanoparticles cross-linked hyaluronic acid photothermal hydrogel with cascading immunoinducible effects for in situ antitumor vaccination. International Journal of Biological Macromolecules. 269(Pt 2). 132177–132177. 15 indexed citations
8.
Chen, Zhang‐Peng, Wen Fang, Zhengge Wang, et al.. (2023). Lipid-accumulated reactive astrocytes promote disease progression in epilepsy. Nature Neuroscience. 26(4). 542–554. 96 indexed citations breakdown →
9.
Xiong, Xinxin, Siyu Chen, Jianfei Shen, et al.. (2022). Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2. Signal Transduction and Targeted Therapy. 7(1). 99–99. 52 indexed citations
10.
Zhang, Yang, Yiran Li, Yaliang Zhang, et al.. (2022). Mannose‐targeting Concanavalin A−Epirubicin Conjugate for Targeted Intravesical Chemotherapy of Bladder Cancer. Chemistry - An Asian Journal. 17(16). e202200342–e202200342. 16 indexed citations
11.
Fu, Yao, Hao Wu, Siqi Zhou, et al.. (2022). Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations. Oncogene. 41(25). 3394–3408. 12 indexed citations
12.
Wang, Zhu A., et al.. (2022). FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. Journal for ImmunoTherapy of Cancer. 10(3). e003939–e003939. 18 indexed citations
13.
Cheng, Rongjie, Fanying Li, Maolei Zhang, et al.. (2022). A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers. Cell Research. 33(1). 30–45. 40 indexed citations
14.
Jiang, Bo, Xiaozhi Zhao, Wei Chen, et al.. (2022). Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nature Communications. 13(1). 4141–4141. 27 indexed citations
15.
Teng, Xiaolei, Yumeng Qi, Xiaosheng Tang, et al.. (2022). Mixed oxidation of chlorophene and 4-tert-butylphenol by ferrate(VI): Reaction kinetics, cross-coupling products and improved utilization efficiency of ferrate(VI). Separation and Purification Technology. 301. 121902–121902. 17 indexed citations
16.
Hu, Huanhuan, Rongjie Cheng, Yanbo Wang, et al.. (2022). Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. Journal of Clinical Investigation. 133(2). 71 indexed citations
17.
18.
Wang, Yanbo, Xiaming Jiang, Zheng Fu, et al.. (2021). Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduction and Targeted Therapy. 6(1). 300–300. 55 indexed citations
19.
Huang, Tengfei, Tianqi Xu, Yangfan Wang, et al.. (2021). Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. Autophagy. 17(11). 3592–3606. 154 indexed citations breakdown →
20.
Wei, Bo, Chengzhe Jin, Yan Xu, et al.. (2014). Chondrogenic Differentiation of Marrow Clots After Microfracture with BMSC-Derived ECM Scaffold In Vitro. Tissue Engineering Part A. 20(19-20). 2646–2655. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026